Standout Papers

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomis... 2004 2026 2011 2018 1.3k
  1. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial (2004)
    Jaap Verweij, Paolo G. Casali et al. The Lancet

Immediate Impact

23 from Science/Nature 66 standout
Sub-graph 1 of 19

Citing Papers

A view on drug resistance in cancer
2019 StandoutNature
Osteosarcoma, Chondrosarcoma, and Chordoma
2017 Standout
1 intermediate paper

Works of Rossella Bertulli being referenced

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
2014
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient
2004

Author Peers

Author Last Decade Papers Cites
Rossella Bertulli 3868 1496 1561 82 5.0k
Martin E. Blackstein 3860 1944 2447 99 6.2k
Vivien Bramwell 2557 2374 1023 74 5.0k
A. van Oosterom 3665 1754 2500 85 6.0k
Narasimhan P. Agaram 3648 2328 766 108 6.2k
Kristen N. Ganjoo 3172 1907 1084 170 5.1k
Emmanuelle Bompas 3990 2560 787 193 5.6k
Binh Bui 3343 2264 817 56 4.5k
Scott H. Okuno 3486 2482 777 177 5.7k
Scott M. Schuetze 6220 3261 1267 166 8.5k
Kirsten Sundby Hall 2325 967 703 103 3.3k

All Works

Loading papers...

Rankless by CCL
2026